KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRent ExpenseShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Universal Health Services (UHS) Depreciation & Amortization (IS) (2016 - 2025)

Universal Health Services' Depreciation & Amortization (IS) history spans 17 years, with the latest figure at $163.3 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) rose 11.28% year-over-year to $163.3 million; the TTM value through Dec 2025 reached $618.7 million, up 5.8%, while the annual FY2025 figure was $618.7 million, 5.8% up from the prior year.
  • Depreciation & Amortization (IS) reached $163.3 million in Q4 2025 per UHS's latest filing, up from $155.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $163.3 million in Q4 2025 to a low of $131.4 million in Q1 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $144.3 million, with a median of $144.7 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (IS): decreased 5.95% in 2023, then rose 11.28% in 2025.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $133.4 million in 2021, then grew by 11.24% to $148.4 million in 2022, then fell by 1.94% to $145.5 million in 2023, then rose by 0.89% to $146.8 million in 2024, then rose by 11.28% to $163.3 million in 2025.
  • Per Business Quant, the three most recent readings for UHS's Depreciation & Amortization (IS) are $163.3 million (Q4 2025), $155.1 million (Q3 2025), and $152.0 million (Q2 2025).